AGIOS PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • Agios Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $5.86M, a 138% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.43M, a 131% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.35M.
  • Agios Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$766M, a 393% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.43M +$3.08M +131% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $2.35M +$768M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$766M -$1.03B -393% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $262M -$28.1M -9.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $290M -$256M -47% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $546M +$261M +91.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $285M +$115M +67.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $170M +$163M +2564% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $6.37M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-14
2013 $124M +$124M +87139% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-18
2012 $142K -$77.2M -99.8% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-18
2011 $77.4M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.